Adina Rachel Kern-Goldberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adina Rachel Kern-Goldberger has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Sindhu K. Srinivas
Hospital of the University of Pennsylvania
9 shared publicationsCynthia Gyamfi-Bannerman
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York
5 shared publicationsLisa D. Levine
4 shared publicationsAlexander Friedman
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York
3 shared publicationsDena Goffman
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York
3 shared publicationsLeslie Moroz
Columbia University Medical Center, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, New York, USA
3 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by Elsevier in The Joint Commission Journal on Quality and Patient Safety
- Vol. 52 (10) , 512-522
A framework to characterize the costs of delayed diagnoses
- 17 June 2026
- Published by Elsevier in The Joint Commission Journal on Quality and Patient Safety
- Vol. 52 (10) , 512-522
Open AccessA framework to characterize the costs of delayed diagnoses
- Open Access
- 25 May 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (8)
Developing a novel patient-centered definition of severe maternal morbidity
- 25 May 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (8)
Open AccessDeveloping a novel patient-centered definition of severe maternal morbidity
- Open Access
Evaluation Oxygen Saturation Monitoring to Detect Pulmonary Edema in Patients with Severe Preeclampsia
Objective: Pulmonary edema is a feature of preeclampsia with severe features (SPEC), but it is unknown whether oxygen saturation (O2 sat) levels can predict pulmonary edema in patients with SPEC. The purpose of this study is to evaluate and compare O2 sat trends in patients with SPEC with and without pulmonary edema. Study Design: This is a nested case-control study within a retrospective cohort of all patients with SPEC who delivered at a tertiary academic hospital in 2019. Cases were defined as a clinical diagnosis of pulmonary edema (based on imaging findings or clinical concern coupled with empiric treatment with IV diuretic) on postpartum day 0 (PPD0). Controls were patients with SPEC and without pulmonary edema on PPD0. All patients with at least 25 oxygen saturation levels recorded on PPD0 were included. O2 sat trends as well as demographic and clinical features of patients with and without pulmonary edema were compared. Results: 238 patients in total were included. Five patients (2.1%) were diagnosed with pulmonary edema on PPD0. There were no significant differences in demographic or major obstetric characteristics of patients with and without pulmonary edema. There were also no significant differences between groups in the number of patients with at least one abnormal O2 sat, with a large volume of abnormal O2 sat values in both groups. Significant differences were seen in the minimum oxygen saturation level recorded (92 v. 89, p < 0.04) and the overall percent of abnormal values (7.0% abnormal values without pulmonary edema compared to 46.0% with pulmonary edema, p < 0.01). Conclusions: Individual O2 sat values are poorly predictive of pulmonary edema in patients at risk, but trends may be more prognostic. Algorithms that employ real-time data trending may position O2 sat as a better surveillance tool for pulmonary edema in patients with SPEC.
Open AccessEvaluation Oxygen Saturation Monitoring to Detect Pulmonary Edema in Patients with Severe Preeclampsia
Objective: Pulmonary edema is a feature of preeclampsia with severe features (SPEC), but it is unknown whether oxygen saturation (O2 sat) levels can predict pulmonary edema in patients with SPEC. The purpose of this study is to evaluate and compare O2 sat trends in patients with SPEC with and without pulmonary edema. Study Design: This is a nested case-control study within a retrospective cohort of all patients with SPEC who delivered at a tertiary academic hospital in 2019. Cases were defined as a clinical diagnosis of pulmonary edema (based on imaging findings or clinical concern coupled with empiric treatment with IV diuretic) on postpartum day 0 (PPD0). Controls were patients with SPEC and without pulmonary edema on PPD0. All patients with at least 25 oxygen saturation levels recorded on PPD0 were included. O2 sat trends as well as demographic and clinical features of patients with and without pulmonary edema were compared. Results: 238 patients in total were included. Five patients (2.1%) were diagnosed with pulmonary edema on PPD0. There were no significant differences in demographic or major obstetric characteristics of patients with and without pulmonary edema. There were also no significant differences between groups in the number of patients with at least one abnormal O2 sat, with a large volume of abnormal O2 sat values in both groups. Significant differences were seen in the minimum oxygen saturation level recorded (92 v. 89, p < 0.04) and the overall percent of abnormal values (7.0% abnormal values without pulmonary edema compared to 46.0% with pulmonary edema, p < 0.01). Conclusions: Individual O2 sat values are poorly predictive of pulmonary edema in patients at risk, but trends may be more prognostic. Algorithms that employ real-time data trending may position O2 sat as a better surveillance tool for pulmonary edema in patients with SPEC.
- 2 April 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (02) , 279-282
External Validation of the Clinical Obstetric Comorbidity Index across a Diverse Health System
The clinically-modified obstetric comorbidity index (OB-CMI) is a comorbidity-based scoring system that has been validated to predict severe maternal morbidity (SMM) in a single tertiary, academic hospital using an internal SMM definition. We aimed to validate the OB-CMI for the prediction of SMM as defined by the CDC during delivery admissions across a diverse health system. This is a retrospective cohort study evaluating all deliveries in a large health system encompassing academic and community hospitals. Data from 2019 to 2021 were extracted from the electronic health record (EHR) and validated with chart review. An OB-CMI score was calculated for each patient using established diagnosis codes and EHR data. The primary outcome was nontransfusion SMM (defined by the CDC) during the delivery admission. Patient characteristics were evaluated by the hospital, and hospital-specific receiver-operator characteristic (ROC) curves were constructed and compared. In total, 42,130 deliveries were included with significant differences in all demographic, clinical, and obstetric characteristics across the hospitals including age, BMI, race/ethnicity, insurance type, preterm birth, and preeclampsia rates. Median OB-CMI score and rate of elevated OB-CMI score (≥6) were also significantly different. ROC curves for OB-CMI and SMM for each hospital are noted in the figure with an area under the curve range from 0.77 to 0.83, and no significant differences across hospitals (p = 0.32). In a large cohort of patients delivering across a diverse hospital system, the clinical OB-CMI score similarly predicted SMM despite differences in demographic and clinical characteristics among the hospitals. This validation of the OB-CMI supports the use of this scoring system in variegated clinical settings, which can inform widescale uptake and clinical integration of OB-CMI scoring to improve obstetric risk stratification.
- 2 April 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (02) , 279-282
External Validation of the Clinical Obstetric Comorbidity Index across a Diverse Health System
The clinically-modified obstetric comorbidity index (OB-CMI) is a comorbidity-based scoring system that has been validated to predict severe maternal morbidity (SMM) in a single tertiary, academic hospital using an internal SMM definition. We aimed to validate the OB-CMI for the prediction of SMM as defined by the CDC during delivery admissions across a diverse health system. This is a retrospective cohort study evaluating all deliveries in a large health system encompassing academic and community hospitals. Data from 2019 to 2021 were extracted from the electronic health record (EHR) and validated with chart review. An OB-CMI score was calculated for each patient using established diagnosis codes and EHR data. The primary outcome was nontransfusion SMM (defined by the CDC) during the delivery admission. Patient characteristics were evaluated by the hospital, and hospital-specific receiver-operator characteristic (ROC) curves were constructed and compared. In total, 42,130 deliveries were included with significant differences in all demographic, clinical, and obstetric characteristics across the hospitals including age, BMI, race/ethnicity, insurance type, preterm birth, and preeclampsia rates. Median OB-CMI score and rate of elevated OB-CMI score (≥6) were also significantly different. ROC curves for OB-CMI and SMM for each hospital are noted in the figure with an area under the curve range from 0.77 to 0.83, and no significant differences across hospitals (p = 0.32). In a large cohort of patients delivering across a diverse hospital system, the clinical OB-CMI score similarly predicted SMM despite differences in demographic and clinical characteristics among the hospitals. This validation of the OB-CMI supports the use of this scoring system in variegated clinical settings, which can inform widescale uptake and clinical integration of OB-CMI scoring to improve obstetric risk stratification.
- 25 March 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (02) , 272-274
The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients
Low-dose aspirin is an established preventive strategy for reducing the risk of preeclampsia in patients with designated risk factors. This prospective observational study evaluated trends in aspirin prescription rates in a multihospital health system over a 10-month period during which a policy to offer low-dose aspirin universally was instituted. A total of 11,382 patients were included and an interrupted time series was used to analyze rates of aspirin prescriptions ordered by 16 weeks, before and after implementation of the universal policy. There were statistically significant increases in aspirin prescription rates for the entire cohort (incidence rate ratio [IRR]: 2.93; 95% confidence interval [CI]: 2.13–4.04) and for a high-risk subcohort including patients with chronic hypertension, pregestational diabetes, and/or multiple gestation (IRR: 1.48; 95% CI: 1.26–1.76). Instituting a policy to offer universal low dose aspirin during pregnancy resulted in significantly increased utilization among patients with high-risk indications for aspirin.
- 25 March 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 43 (02) , 272-274
The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients
Low-dose aspirin is an established preventive strategy for reducing the risk of preeclampsia in patients with designated risk factors. This prospective observational study evaluated trends in aspirin prescription rates in a multihospital health system over a 10-month period during which a policy to offer low-dose aspirin universally was instituted. A total of 11,382 patients were included and an interrupted time series was used to analyze rates of aspirin prescriptions ordered by 16 weeks, before and after implementation of the universal policy. There were statistically significant increases in aspirin prescription rates for the entire cohort (incidence rate ratio [IRR]: 2.93; 95% confidence interval [CI]: 2.13–4.04) and for a high-risk subcohort including patients with chronic hypertension, pregestational diabetes, and/or multiple gestation (IRR: 1.48; 95% CI: 1.26–1.76). Instituting a policy to offer universal low dose aspirin during pregnancy resulted in significantly increased utilization among patients with high-risk indications for aspirin.
- 17 March 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Evaluating Risk-Adjusted Associations between Prenatal Care Utilization and Obstetric Outcomes in a Commercially Insured Patient Population
Office prenatal care has followed a similar structure for the past century. It is largely unknown whether attendance at routine outpatient antenatal visits prevents major adverse maternal outcomes. This study examined associations between prenatal care utilization and adverse obstetric outcomes including severe maternal morbidity (SMM), preterm birth, and stillbirth in a large, commercially insured US patient population.This is a retrospective cohort study using an insurance claims database evaluating associations between prenatal care utilization and obstetric outcomes over 4 years (2017–2020). Prenatal care utilization was characterized based on the adequacy of prenatal care utilization (APNCU) index. The primary outcome was SMM (as per Centers for Disease Control). Secondary outcomes included preterm birth <37 weeks and stillbirth. Associations between exposure and outcome were investigated using logistic regression models in designated “low” and “medium” maternal risk groups, defined based on obstetric co-morbidity index (OB-CMI) scores modeled at the time of the first trimester and at delivery.A total of 297,453 patients were included: 78,100 in the sub-group who remained low-risk throughout pregnancy and 49,920 in the sub-group who remained medium-risk. The largest number of patients overall (29.9%) received “adequate plus” care, as defined by the APNCU index, while a plurality of low- and medium-risk patients received “intermediate” care (35.6 and 29.9%, respectively). One point seventy seven percent of patients experienced SMM, 8.63% delivered preterm, and 0.88% had stillbirth. Adjusted analysis comparing volume of prenatal care with these outcomes demonstrated no statistically significant associations, with the exception of preterm birth, which was positively associated with “adequate” and “adequate plus” care in low- and medium-risk patients. “Inadequate care” was not associated with any of the studied outcomes.Overall volume of prenatal care was not associated with a reduction in adverse obstetric outcomes. Clinical quality improvement and health policy efforts to improve prenatal care delivery models may need to bypass adherence to established guidelines in terms of gross visit number as a key metric and instead work to revise practices based on more meaningful clinical outcomes.
- 17 March 2025
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Evaluating Risk-Adjusted Associations between Prenatal Care Utilization and Obstetric Outcomes in a Commercially Insured Patient Population
Office prenatal care has followed a similar structure for the past century. It is largely unknown whether attendance at routine outpatient antenatal visits prevents major adverse maternal outcomes. This study examined associations between prenatal care utilization and adverse obstetric outcomes including severe maternal morbidity (SMM), preterm birth, and stillbirth in a large, commercially insured US patient population.This is a retrospective cohort study using an insurance claims database evaluating associations between prenatal care utilization and obstetric outcomes over 4 years (2017–2020). Prenatal care utilization was characterized based on the adequacy of prenatal care utilization (APNCU) index. The primary outcome was SMM (as per Centers for Disease Control). Secondary outcomes included preterm birth <37 weeks and stillbirth. Associations between exposure and outcome were investigated using logistic regression models in designated “low” and “medium” maternal risk groups, defined based on obstetric co-morbidity index (OB-CMI) scores modeled at the time of the first trimester and at delivery.A total of 297,453 patients were included: 78,100 in the sub-group who remained low-risk throughout pregnancy and 49,920 in the sub-group who remained medium-risk. The largest number of patients overall (29.9%) received “adequate plus” care, as defined by the APNCU index, while a plurality of low- and medium-risk patients received “intermediate” care (35.6 and 29.9%, respectively). One point seventy seven percent of patients experienced SMM, 8.63% delivered preterm, and 0.88% had stillbirth. Adjusted analysis comparing volume of prenatal care with these outcomes demonstrated no statistically significant associations, with the exception of preterm birth, which was positively associated with “adequate” and “adequate plus” care in low- and medium-risk patients. “Inadequate care” was not associated with any of the studied outcomes.Overall volume of prenatal care was not associated with a reduction in adverse obstetric outcomes. Clinical quality improvement and health policy efforts to improve prenatal care delivery models may need to bypass adherence to established guidelines in terms of gross visit number as a key metric and instead work to revise practices based on more meaningful clinical outcomes.
- 15 February 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (5) , 101653
The role of incorporating maternal-fetal medicine physicians onto labor and delivery in reducing maternal morbidity
- 15 February 2025
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 7 (5) , 101653
The role of incorporating maternal-fetal medicine physicians onto labor and delivery in reducing maternal morbidity
- 18 October 2024
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 6 (12) , 101529
Trends in severe maternal morbidity following an institutional team goal strategy for disparity reduction
- 18 October 2024
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 6 (12) , 101529
Trends in severe maternal morbidity following an institutional team goal strategy for disparity reduction
- 4 November 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 230 (5) , B6-B11
Society for Maternal-Fetal Medicine Special Statement: Utilizing telemedicine to address disparities in maternal-fetal medicine: a call to policy action
- 4 November 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 230 (5) , B6-B11
Society for Maternal-Fetal Medicine Special Statement: Utilizing telemedicine to address disparities in maternal-fetal medicine: a call to policy action
- 10 February 2023
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 5 (5) , 100893
The impact of an intervention to improve intrapartum maternal vital sign monitoring and reduce alarm fatigue
- 10 February 2023
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 5 (5) , 100893
The impact of an intervention to improve intrapartum maternal vital sign monitoring and reduce alarm fatigue